Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
230 USD | +0.44% | -4.19% | -2.97% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.97% | 11.76B | |
-0.01% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.58% | 24.63B | |
-23.54% | 18.2B | |
+27.64% | 12.01B | |
+15.28% | 10.4B | |
-5.12% | 9.94B | |
-4.59% | 9.39B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories International : Citigroup Downgrades Charles River to Neutral From Buy, Adjusts Price Target to $250 From $270